References
Leopold WR, Nelson JM, Plowman J,et al.: Anthapyrazoles, a new class of intercalating agents with high level, broad spectrum activity against murine tumors. Cancer Res 45:5532–5539, 1985
Showalter HDH, Johnson JL, Hofteizer JM,et al.: Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias. J Med Chem 30(1): 121–131, 1987
Erlichman C, Moore M, Kerr I, Wong B, Eisenhauer E, Zee B, Whitfield L: A Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole CI-937 (DuP 937). Cancer Research 51:6317–6322, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maroun, J.A., Skillings, J., MacCormick, R. et al. Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma. Invest New Drugs 11, 235–237 (1993). https://doi.org/10.1007/BF00874163
Issue Date:
DOI: https://doi.org/10.1007/BF00874163